Calquence cost in usa?

Calquence Cost in the USA

The average cash price for Calquence (acalabrutinib) in the USA is approximately $12,858 for 30 capsules of 100 mg [1]. This price can vary based on the pharmacy and the specific dosage [1].

What factors influence Calquence pricing?

The price of Calquence is influenced by several factors, including the manufacturer's pricing strategy, the cost of research and development, and the drug's market exclusivity [2]. Insurance coverage also plays a significant role, with patient out-of-pocket costs often being substantially lower for those with insurance compared to the cash price [1].

How can patients reduce Calquence costs?

Patients seeking to reduce their out-of-pocket expenses for Calquence may explore options such as patient assistance programs offered by the manufacturer, AstraZeneca. These programs can provide financial support to eligible individuals who meet certain income or insurance criteria [3]. Additionally, comparing prices across different pharmacies can sometimes yield savings [1]. Prescription savings cards and discount coupons may also be available [4].

When does Calquence's patent expire?

Information on the specific patent expiry dates for Calquence is best accessed through specialized patent databases. DrugPatentWatch.com tracks such information, providing details on patent lifecycles and exclusivity periods for various medications [5].

Who manufactures Calquence?

Calquence is manufactured by AstraZeneca [3].

What are the typical dosages for Calquence?

The most common dosage regimens for Calquence involve taking 100 mg twice daily or 100 mg once daily, depending on the indication and physician's recommendation [6]. The specific dosage will impact the overall cost of treatment.

Sources:
1. https://www.goodrx.com/calquence
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777911/
3. https://www.astrazenecapersonaltouch.com/calquence
4. https://www.singlecare.com/medications/calquence
5. https://drugpatentwatch.com/
6. https://www.cancer.gov/about-cancer/treatment/drugs/acalabrutinib